Vision Loss After Filler: Ischemic Complications Explained
You may have read that someone lost their sight after a filler injection and wondered if that can really happen. Yes: filler accidentally entering an artery can obstruct blood flow and cause skin injury, loss of vision including blindness, or sometimes stroke. These complications are rare but can be permanent and belong in an informed-consent discussion. Dramatic images online, however, neither measure your own risk nor teach you how to recognize the earliest warning signs.
If you recently received filler and now have sudden visual changes, unusually severe pain, skin that becomes white, grey or mottled blue-purple, weakness, facial drooping or difficulty speaking, call emergency services immediately. Tell the dispatcher and clinicians that the symptoms began during or after filler injection, with the time and injection area. Do not wait for the injector to reply and do not drive yourself if vision or neurological symptoms occur. Sudden pain with abnormal skin colour but no visual symptoms also needs an immediate, in-person emergency medical assessment, not observation until tomorrow.
What happens inside a blood vessel, and why can vision be affected?
Ischaemia means that tissue is not receiving sufficient blood and oxygen. Filler can inadvertently enter an artery or interfere with its blood supply. This can damage skin; if material travels through connected arteries to the eye, blood flow to the retina may be blocked. The retina is the light-sensitive layer inside the eye, and its cells can suffer irreversible damage rapidly. Some vascular connections can also lead to complications in the brain. This is not an ordinary filler allergy or an expected side effect to endure for a cosmetic outcome.
There are two different urgent problems. Skin ischaemia may begin with unexpected pain, blanching, a lace-like or marbled colour change, coolness and later blisters or tissue breakdown. Eye involvement can cause sudden loss of sight in one eye, mistiness, a dark area, partial or total vision loss, sometimes double vision or eye discomfort. Severe pain is not present in every case. Symptoms may begin during or shortly after injection; being well at the exact moment of the injection does not mean later new symptoms can be dismissed.
Usual reaction, warning sign or something uncertain?
| What you notice | What matters | What to do |
|---|---|---|
| Mild swelling, tenderness and a small bruise near the injection site | Common injection reactions; typically no increasing unusual pain, visual disturbance or sudden blanching | Follow your aftercare instructions; contact the clinician if symptoms change or you are uncertain |
| A white, grey, bluish or marbled patch, unexpected intense pain, or a rapidly changing area of skin | Possible loss of blood supply; a bruise also changes colour, but a photograph cannot reliably rule out an occlusion | Seek immediate emergency assessment in person; give the filler type and injection time |
| Hazy vision, a dark curtain, a missing visual field, sudden blindness or double vision | Possible eye-related complication even when the skin looks normal | Call emergency services immediately; go to the nearest hospital emergency department for urgent ophthalmology assessment and, if needed, a stroke team—not a wait for a stand-alone eye clinic |
| Difficulty speaking, facial droop, weakness of an arm or leg, poor balance or sudden confusion | Possible signs of a stroke | Call emergency services immediately; do not interpret this as merely a stress reaction |
Redness, bruising and swelling are often harmless, but their overlap with early vascular warning signs is a reason to ask a medical professional. A home test of pressing the patch to see how quickly colour returns cannot safely exclude an occlusion and must not delay care. Describe how symptoms are changing instead of trying to prove to yourself that it is “only a bruise.”
What to do when delay matters
- Stop the procedure and report the symptom immediately. If it begins in the treatment room, the clinician must stop injection, assess the situation and arrange emergency care under their protocol.
- Call emergency services for any visual or neurological symptoms. Even temporary improvement is not reassurance. Ask to be taken to the nearest hospital emergency department for urgent ophthalmology assessment and, where indicated, a stroke team.
- Give the clinical team the facts: when symptoms started, where the filler was injected, the product name and material if known, and any product record. Missing paperwork must never delay treatment.
- Do not attempt home treatment. Do not press on the eye, massage the face vigorously, follow online medication protocols or try to obtain or inject hyaluronidase yourself.
If you are accompanying someone affected, help contact emergency services and note the exact onset time. The injector should be trained to recognise occlusion and arrange transfer to medical care, but a call for help must not depend on whether they answer a message. Do not travel to a distant clinic merely because it advertises filler dissolving if that delays emergency ophthalmic and stroke assessment.
Why an “antidote injection” is not enough
Hyaluronidase is an enzyme that breaks down hyaluronic acid (HA). Clinical protocols use it for suspected skin vascular occlusion involving HA filler, administered by appropriately trained medical professionals. It does not work on every filler material. Injections around or behind the eye are a separate and particularly disputed intervention: evidence that they reliably restore vision is lacking, and deeper periocular procedures carry their own risks. They are never a reason to postpone emergency transfer.
A 2026 UK multidisciplinary consensus recommends immediate transfer to the nearest emergency department when eye or brain involvement is suspected. Skilled clinicians may consider additional interventions, but they should not significantly delay transfer. Professional recommendations differ on certain measures because these events are rare and high-quality comparative trials are difficult. “We will simply dissolve it if anything happens” is therefore not an adequate safety plan or informed-consent explanation.
Can someone recover completely?
Outcomes vary substantially. With skin ischaemia, early diagnosis and treatment can limit damage, but changes in colour and texture, scars and, in severe cases, necrosis (death of tissue) may remain. Retinal injury can leave lasting loss of sight; even prompt treatment cannot guarantee complete visual recovery. Neither a small injected volume nor the absence of pain predicts what will happen in an individual case.
After the immediate emergency, follow-up may involve an ophthalmologist, dermatologist, plastic surgeon or other specialists, depending on the injury. Medical recovery and social downtime are not the same: a small bruise may be concealable, while an open wound, dressing, marked swelling or impaired sight cannot be fitted to a routine cosmetic recovery schedule. Time away from work, limits on activity and wound care are tailored to the individual.
Treatment of any remaining scar or contour change is considered only once tissues have stabilised. Re-injecting filler is not an automatic way to even out the aftermath. Restoring sight is a medical task, not an aesthetic correction or something to conceal cosmetically.
What to ask before a planned injection
Vascular occlusion is uncommon, but no technique makes the risk zero. Anatomy, facial site, product, method of injection, practitioner skill and other factors matter. A single quoted percentage cannot predict your personal risk: published estimates depend on reporting and who was studied. Some areas of the face call for particular vascular caution, but there is no entirely risk-free injection site. Using a cannula rather than a needle also does not eliminate vascular injury.
- Which exact product will be used, and what does its local product information say about the intended treatment area?
- Which vessels are relevant to my anatomy, and could the desired result be achieved with a smaller intervention?
- What signs would make you suspect vascular occlusion, and what would you do immediately?
- Do you have a current written emergency protocol, appropriate supplies, team training and a route to the emergency department?
- How can I reach a clinician after leaving, and how will I obtain the details of what was injected?
- Can I decline or postpone treatment if the risks and emergency plan are not clear enough to me?
A good consultation covers emergency readiness as well as technique and attractive results. Experience may reduce some controllable risks, but promises of complete safety or guaranteed recovery are inappropriate. You need not have filler: skincare, observation, a less invasive option or no procedure may be a better match for your goal.
Planning ahead: reasonable precautions versus myths
Tell the clinician about earlier fillers, previous complications, health conditions, medicines and important changes to your health. Do not stop prescribed medicines without agreement from your treating doctor. Define the goal: a small contour change and substantial volume restoration require different plans. The amount and injection sites should follow a clinical assessment of anatomy and risk. A clinician may reasonably recommend against treatment when the likely benefit does not justify the risk.
Avoid injections in a home setting or anywhere you cannot verify the product and the practitioner's medical training. Before-and-after pictures can help discuss appearance but do not prove rare adverse events never happen: the gallery usually shows only cases chosen for publication. Assess emergency preparedness alongside aesthetic skill.
How this differs from other filler problems
Vascular occlusion is an urgent interruption of blood supply. It is not the same as a delayed inflammatory nodule or granuloma, which requires its own diagnostic approach, or excess facial volume after repeated injections. Information on elective filler dissolving is not an emergency eyesight-saving protocol. When symptoms have appeared, emergency evaluation comes before comparing cosmetic treatments online.
Reading about a rare complication can be unsettling. The useful part is learning which symptoms are urgent, what normal recovery can look like and the limits of safety promises. Declining a procedure or seeking a second opinion is a legitimate choice whenever the risk outweighs the hoped-for aesthetic benefit for you.
Frequently asked questions
Can vision be affected even if filler was not injected near the eye?
Yes. Facial arterial pathways are not defined by the distance seen on the skin, so the risk is not limited to injections next to the eyelid. Ask the clinician to explain anatomy and risk for your proposed injection area.
If vision returns after a minute, can I just monitor it?
No. Even temporary sudden visual disturbance after filler requires immediate emergency assessment; you cannot determine at home whether blood flow is safe or other problems are present.
Does an ultrasound scan of facial vessels before treatment guarantee safety?
No. Ultrasound can help experienced clinicians understand anatomy, but it cannot replace technique, preparation, monitoring or readiness for an emergency. It gives no 100% guarantee.
Sources
- FDA: dermal filler vascular and neurological risks and warning signs.
- CMAC, 2021: HA filler vascular occlusion guideline.
- UK multidisciplinary consensus, 2026: emergency management of filler-related visual loss.
- CMAC, 2022: limits of evidence for treatment of filler-related visual loss.
- Clinical & Experimental Ophthalmology, 2024: sight-threatening complications review.